Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.610
+0.030 (1.90%)
At close: Apr 24, 2025, 4:00 PM
1.520
-0.090 (-5.59%)
Pre-market: Apr 25, 2025, 4:19 AM EDT

BDTX Stock Forecast

BDTX's stock price has decreased by -67.86% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BDTX stock have an average target of 15.6, with a low estimate of 12 and a high estimate of 20. The average target predicts an increase of 868.94% from the current stock price of 1.61.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $12 $15.6 $15 $20
Change +645.34% +868.94% +831.68% +1142.2%
* Price targets were last updated on Mar 18, 2025.

Analyst Ratings

The average analyst rating for BDTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy 111122
Buy 333333
Hold 000000
Sell 000000
Strong Sell 000000
Total 444455

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11$12
Strong Buy Maintains $11$12 +645.34% Mar 18, 2025
Stifel
Stifel
Strong Buy
Maintains
$16$15
Strong Buy Maintains $16$15 +831.68% Mar 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +583.23% Nov 6, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$11
Strong Buy Reiterates $11 +583.23% Oct 9, 2024
Wedbush
Wedbush
Buy
Reiterates
$16
Buy Reiterates $16 +893.79% Oct 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 175.97M
Revenue Next Year
n/a
EPS This Year
-1.06
from -1.27
EPS Next Year
-1.17
from -1.06
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
28.56M-9.59M47.59M175.97M
Revenue Growth
---396.21%269.79%---
EPS
-2.05-3.47-2.51-1.88-1.27-1.06-1.17-1.56
EPS Growth
--------
Forward PE
--------
No. Analysts
-----988
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 73.5M n/a 20.9M
Avg 28.6M n/a 9.6M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
-58.2%
- -
Avg
-83.8%
- -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -0.66 -0.78 -0.67
Avg -1.06 -1.17 -1.56
Low -1.29 -1.45 -2.65

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.